Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for Alcohol Use Disorder
NCT04322305Phase 2Suspended
- Sponsor
- New York State Psychiatric Institute
- Start
- Jan 2021
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pregabalin in alcohol use disorder (AUD), sponsored by New York State Psychiatric Institute. Started Jan 2021; status: suspended.
02
Drugs
pregabalin
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT04322305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04322305.